Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|October 4, 2019
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patientsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Mariana Díaz-Almirón, et al.
Oncotarget|July 3, 2018
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancerAndrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
BMC Cancer|June 30, 2019
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunitiesLucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Cancers|February 25, 2023
A Novel Molecular Analysis Approach in Colorectal Cancer Suggests New Treatment OpportunitiesElena López-Camacho, Guillermo Prado-Vázquez, Daniel Martínez-Pérez, et al.
Plos One|June 9, 2017
Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomicsAngelo Gámez-Pozo, Lucía Trilla-Fuertes, Guillermo Prado-Vázquez, et al.
BMC Cancer|April 16, 2020
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancerLucía Trilla-Fuertes, Angelo Gámez-Pozo, Elena López-Camacho, et al.
Scientific Reports|May 12, 2019
Melanoma proteomics suggests functional differences related to mutational statusLucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Scientific Reports|February 9, 2019
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognosesGuillermo Prado-Vázquez, Angelo Gámez-Pozo, Lucía Trilla-Fuertes, et al.
Plos One|February 29, 2020
miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinomaLucía Trilla-Fuertes, Natalia Miranda, Daniel Castellano, et al.
Ecancermedicalscience|February 23, 2019
Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancerKaterin Rojas L, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, et al.
Pageof 2